Steven George Hughes Insider Profile
4 Followers
Steven George Hughes, CMO at Atrium Therapeutics, Inc., holds 51.64K shares in Atrium Therapeutics, Inc. (Ticker: RNA), holds 138.48K shares in VivoSim Labs (Ticker: VIVS), holds ― shares in Arcturus Therapeutics (Ticker: ARCT).
Steven George Hughes has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Steven George Hughes holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Steven George Hughes
Steven George Hughes's Trading History
Atrium Therapeutics, Inc.
Sep 22, 2026
CMO
Uninformative Sell
192.06K
$427.56K
VivoSim Labs
Aug 19, 2019
CMO
Informative Sell
6.22K
$29.36K
Arcturus Therapeutics
―
CDO
―
―
Avidity Biosciences
Feb 27, 2026
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Steven George Hughes's performance on stock
You May Also Like
Steven George Hughes insider profile FAQ
What is the percentage of profitable transactions made by Steven George Hughes?
The percentage of profitable transactions made by Steven George Hughes is ―.
What is the average return per transaction made by Steven George Hughes?
The average return per transaction made by Steven George Hughes is ―.
What stocks does Steven George Hughes hold?
Steven George Hughes holds: RNA, VIVS, ARCT, RNAM stocks.
What was Steven George Hughes’s latest transaction?
Steven George Hughes latest transaction was an Uninformative Sell of $192.06K.
What was Steven George Hughes's most profitable transaction?
Steven George Hughes’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Steven George Hughes's role in Atrium Therapeutics, Inc.?
Steven George Hughes's role in Atrium Therapeutics, Inc. is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.